Cargando…
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation
AMPK acts downstream of the tumor suppressor LKB1, yet its role in cancer has been controversial. AMPK is activated by biguanides, such as metformin and phenformin, and metformin use in diabetics has been associated with reduced cancer risk. However, whether this is mediated by cell-autonomous AMPK...
Autores principales: | Vara-Ciruelos, Diana, Dandapani, Madhumita, Russell, Fiona M., Grzes, Katarzyna M., Atrih, Abdelmadjid, Foretz, Marc, Viollet, Benoit, Lamont, Douglas J., Cantrell, Doreen A., Hardie, D. Grahame |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484776/ https://www.ncbi.nlm.nih.gov/pubmed/30995468 http://dx.doi.org/10.1016/j.celrep.2019.03.067 |
Ejemplares similares
-
Mechanism of Activation of AMPK by Cordycepin
por: Hawley, Simon A., et al.
Publicado: (2020) -
Mechanisms of Paradoxical Activation of AMPK by the Kinase Inhibitors SU6656 and Sorafenib
por: Ross, Fiona A., et al.
Publicado: (2017) -
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?(†)
por: Vara-Ciruelos, Diana, et al.
Publicado: (2019) -
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
por: Zarrouk, Marouan, et al.
Publicado: (2014) -
AMPKα1: A glucose sensor that controls CD8 T-cell memory
por: Rolf, Julia, et al.
Publicado: (2013)